Extending AAV Packaging Cargo through Dual Co-Transduction: Efficient Protein Trans-Splicing at Low Vector Doses.
AAV co-transduction
dual AAV vector
dual AAV-intein mediated systems
full capsid enrichment
split-inteins
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Jun 2023
23 Jun 2023
Historique:
received:
19
05
2023
revised:
16
06
2023
accepted:
19
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Adeno-associated viral (AAV) vectors represent one of the leading platforms for gene delivery. Nevertheless, their small packaging capacity restricts their use for diseases requiring large-gene delivery. To overcome this, dual-AAV vector systems that rely on protein trans-splicing were developed, with the split-intein Npu DnaE among the most-used. However, the reconstitution efficiency of Npu DnaE is still insufficient, requiring higher vector doses. In this work, two split-inteins, Cfa and Gp41-1, with reportedly superior trans-splicing were evaluated in comparison with Npu DnaE by transient transfections and dual-AAV in vitro co-transductions. Both Cfa and Gp41-1 split-inteins enabled reconstitution rates that were over two-fold higher than Npu DnaE and 100% of protein reconstitution. The impact of different vector preparation qualities in split-intein performances was also evaluated in co-transduction assays. Higher-quality preparations increased split-inteins' performances by three-fold when compared to low-quality preparations (60-75% vs. 20-30% full particles, respectively). Low-quality vector preparations were observed to limit split-gene reconstitutions by inhibiting co-transduction. We show that combining superior split-inteins with higher-quality vector preparations allowed vector doses to be decreased while maintaining high trans-splicing rates. These results show the potential of more-efficient protein-trans-splicing strategies in dual-AAV vector co-transduction, allowing the extension of its use to the delivery of larger therapeutic genes.
Identifiants
pubmed: 37445701
pii: ijms241310524
doi: 10.3390/ijms241310524
pmc: PMC10341399
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES, Portugal)
ID : UIDB/04462/2020, UIDP/04462/2020, LA/P/0087/2020
Références
J Biol Chem. 2012 Aug 17;287(34):28686-96
pubmed: 22753413
Mol Microbiol. 2003 Dec;50(5):1569-77
pubmed: 14651639
AAPS J. 2022 Nov 22;25(1):3
pubmed: 36414847
Hum Gene Ther Methods. 2016 Feb;27(1):1-12
pubmed: 26757051
Hum Gene Ther. 2020 Jan;31(1-2):47-56
pubmed: 31916856
J Am Chem Soc. 2013 Dec 11;135(49):18673-81
pubmed: 24236406
Nucleic Acids Res. 2009 May;37(8):2560-73
pubmed: 19264795
Nucleic Acids Res. 2015 Jul 27;43(13):6450-8
pubmed: 26082496
EMBO Mol Med. 2014 Feb;6(2):194-211
pubmed: 24150896
J Am Chem Soc. 2012 Jul 18;134(28):11338-41
pubmed: 22734434
Hum Gene Ther. 2008 Sep;19(9):958-64
pubmed: 18788906
Hum Mol Genet. 2015 Dec 1;24(23):6811-25
pubmed: 26420842
Gene Ther. 2014 Apr;21(4):450-6
pubmed: 24572793
Genes (Basel). 2019 Apr 09;10(4):
pubmed: 30970639
Biochem Biophys Res Commun. 2016 Sep 30;478(4):1732-8
pubmed: 27614311
Mol Ther Methods Clin Dev. 2022 Nov 15;27:491-501
pubmed: 36458114
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9226-31
pubmed: 9689062
Sci Transl Med. 2019 May 15;11(492):
pubmed: 31092694
Nat Commun. 2021 Jun 17;12(1):3719
pubmed: 34140489
Chem Commun (Camb). 2019 Jan 24;55(9):1287-1290
pubmed: 30633261
Mol Ther Methods Clin Dev. 2020 May 13;17:1167-1177
pubmed: 32518805
Proc Natl Acad Sci U S A. 1983 Jan;80(2):477-81
pubmed: 6300847
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8538-8543
pubmed: 28739907
Sci Rep. 2018 Mar 27;8(1):5271
pubmed: 29588490
J Virol. 2016 Jul 27;90(16):7019-7031
pubmed: 27147738
Pharmaceutics. 2021 May 18;13(5):
pubmed: 34070226
J Am Chem Soc. 2016 Feb 24;138(7):2162-5
pubmed: 26854538
Mol Biosyst. 2008 Jun;4(6):599-605
pubmed: 18493658
Biotechnol J. 2021 Jan;16(1):e2000015
pubmed: 33002276
Mol Ther Methods Clin Dev. 2021 Oct 19;23:448-459
pubmed: 34786437
Protein Expr Purif. 2022 Oct;198:106132
pubmed: 35750296
Hum Gene Ther. 2018 Aug;29(8):886-901
pubmed: 29641320
J Virol. 2002 Jan;76(2):791-801
pubmed: 11752169
Proc Natl Acad Sci U S A. 1982 Aug;79(16):5038-41
pubmed: 6956912
Hum Gene Ther Methods. 2014 Apr;25(2):166-77
pubmed: 24568220
Front Neurosci. 2017 Sep 08;11:503
pubmed: 28943836
Int J Mol Sci. 2019 Jul 15;20(14):
pubmed: 31311175
Nucleic Acids Res. 1986 Apr 11;14(7):3103-18
pubmed: 3008106
Cells. 2023 Mar 01;12(5):
pubmed: 36899921